Blood work is included in dementia testing because doctors need to rule out other medical conditions that can mimic or cause dementia symptoms. A patient presenting with memory loss, confusion, or cognitive decline could actually have a vitamin B12 deficiency, an underactive thyroid, or untreated diabetes—all of which produce symptoms identical to dementia but are treatable and reversible.
For example, a 68-year-old woman experiencing six months of forgetfulness and difficulty concentrating might receive a dementia diagnosis, but blood tests could reveal severe hypothyroidism, which when treated with thyroid hormone replacement, completely reverses her cognitive symptoms within weeks. Blood tests also assess whether the kidneys and liver are functioning properly, check for infections or chronic inflammation, and measure whether key nutrients are present in adequate amounts. These tests give clinicians a clearer picture of what might actually be happening before attributing cognitive changes to neurodegeneration.
Table of Contents
- Which Treatable Conditions Show Up in Dementia Blood Screening?
- Why Some Dementia Cases Are Missed Without Blood Testing
- Nutritional Deficiencies and Their Effect on Memory and Cognition
- Thyroid Function and Metabolic Screening in Dementia Workup
- Liver and Kidney Function and Medication Metabolism in Older Adults
- Infection and Inflammation as Hidden Drivers of Cognitive Decline
- Lipid Profiles and Cardiovascular Risk as Brain Health Markers
Which Treatable Conditions Show Up in Dementia Blood Screening?
Many medical conditions produce cognitive symptoms that are sometimes mistaken for early Alzheimer’s or other forms of dementia. Hypothyroidism (an underactive thyroid) is one of the most common; it slows metabolism throughout the body and the brain, leading to confusion, poor concentration, memory lapses, and slowed thinking. Vitamin B12 deficiency causes similar cognitive problems and can progress to permanent neurological damage if left untreated. A 2020 study found that up to 10% of older adults have B12 deficiency, and many experience cognitive symptoms before physical ones appear.
Depression is another condition frequently confused with dementia, especially in older adults. It produces what’s called “pseudodementia”—the person appears cognitively impaired, but brain imaging and cognitive testing reveal no actual neurodegeneration. Blood work helps rule out metabolic causes of depression (low thyroid function, vitamin deficiencies) and guides the clinician toward the correct diagnosis. Uncontrolled diabetes, abnormal calcium levels from parathyroid disease, and liver or kidney dysfunction all present with cognitive symptoms that blood work can identify.
Why Some Dementia Cases Are Missed Without Blood Testing
One of the largest blind spots in dementia diagnosis is the assumption that cognitive decline must be permanent and progressive. Clinicians who skip or minimally perform blood work risk misdiagnosing a treatable condition as irreversible dementia. A patient with normal-pressure hydrocephalus (fluid buildup in the brain), for instance, may show dementia-like symptoms, but blood work showing kidney dysfunction (which can impair fluid regulation) might prompt imaging that reveals the correct diagnosis. Similarly, patients with frontotemporal dementia are sometimes initially evaluated without comprehensive blood testing, missing the opportunity to identify concurrent thyroid disease or infection that exacerbates symptoms.
The limitation here is that blood work alone cannot diagnose most dementias—it rules out imitators but does not confirm Alzheimer’s or Lewy body disease. Blood biomarkers for amyloid and tau, the hallmark proteins of Alzheimer’s, exist and are increasingly used, but they are not yet part of every standard dementia workup. Without these newer tests, a dementia diagnosis often rests on clinical presentation, cognitive testing, and brain imaging, not blood alone. This is why comprehensive testing includes both traditional metabolic panels and, increasingly, specialized amyloid/tau blood tests.
Nutritional Deficiencies and Their Effect on Memory and Cognition
Vitamin B12 is stored in the liver and used by the nervous system to maintain myelin, the insulation around nerve fibers. Without adequate B12, nerve transmission slows and brain cells struggle to communicate. Older adults absorb B12 less efficiently from food, and those taking certain medications (like metformin for diabetes) have even higher risk of deficiency. Folate deficiency works similarly; both are critical for a process called methylation, which affects gene expression throughout the brain.
Vitamin D deficiency is increasingly linked to cognitive decline and depression in aging adults. A 65-year-old man living in a northern climate, limited by arthritis to indoor activity, might develop severe vitamin D deficiency without realizing it. His cognitive symptoms—poor concentration, mood changes, slow processing—could all improve significantly with vitamin D supplementation, which is why blood work measuring 25-hydroxyvitamin D is part of a thorough dementia screening. Iron deficiency can cause brain fog and difficulty concentrating by impairing oxygen transport to the brain. Without blood testing for ferritin and iron levels, these conditions go unrecognized and untreated.
Thyroid Function and Metabolic Screening in Dementia Workup
Thyroid-stimulating hormone (TSH) is one of the most frequently ordered tests in dementia screening because thyroid dysfunction is both common and treatable. A TSH level that is too high indicates the thyroid is underactive; a level that is too low might indicate overactivity. Both states disrupt cognitive function. The tradeoff is that mild TSH elevation does not always produce noticeable symptoms, so clinicians must decide whether to treat borderline thyroid dysfunction when cognitive symptoms are present.
Glucose control is another critical metabolic measure. Diabetes and prediabetes both accelerate cognitive decline through multiple mechanisms: they damage small blood vessels in the brain, promote inflammation, and increase amyloid accumulation. A person with uncontrolled diabetes (hemoglobin A1C above 8) is at significantly higher risk of developing dementia compared to someone with tightly controlled blood sugar. Fasting glucose and hemoglobin A1C tests reveal whether metabolic dysfunction is contributing to cognitive symptoms. Some patients find that aggressive management of their blood sugar measurably improves their thinking and memory, though this is more likely when the metabolic dysfunction is recent and the cognitive decline is mild.
Liver and Kidney Function and Medication Metabolism in Older Adults
The liver breaks down medications, and the kidneys filter them out. As people age, both organs work less efficiently, meaning drugs can accumulate to toxic levels in the bloodstream. A patient on four or five medications for heart disease and high blood pressure might unknowingly develop toxicity from a drug that was safe at a younger age, and that toxicity presents as confusion, poor memory, and altered mental status. Blood work measuring liver enzymes (AST, ALT) and kidney function (creatinine, eGFR) helps clinicians identify whether medication-induced cognitive symptoms are occurring.
A serious warning: older adults are particularly vulnerable to anticholinergic medications, which have strong associations with increased dementia risk. These drugs (used for urinary incontinence, depression, allergies, and other conditions) impair neurotransmitter function in the brain. Blood work cannot directly detect anticholinergic toxicity, but kidney and liver function tests help determine whether these medications are accumulating to dangerous levels. If kidney function is declining, doses must be reduced or medications changed.
Infection and Inflammation as Hidden Drivers of Cognitive Decline
A urinary tract infection (UTI) is a classic example of a treatable condition that causes dementia-like symptoms in older adults. An 82-year-old woman might present with acute confusion, disorientation, and poor memory. Her family interprets this as a sudden onset of dementia, but urinalysis and urine culture reveal a severe UTI.
After antibiotic treatment, her cognition returns to baseline. This scenario is common enough that UTI screening is part of standard dementia evaluation in older adults. Chronic inflammation—measured by inflammatory markers like C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR)—is increasingly recognized as a risk factor for cognitive decline and Alzheimer’s disease. Persistent infection (like Helicobacter pylori, which infects the stomach), uncontrolled rheumatoid arthritis, or chronic periodontal disease all elevate inflammatory markers and are associated with worse cognitive outcomes.
Lipid Profiles and Cardiovascular Risk as Brain Health Markers
Cholesterol and lipid levels affect brain health more than many people realize. The brain requires cholesterol to build and repair cell membranes and to support neurotransmitter function. However, high LDL cholesterol promotes atherosclerosis—the buildup of plaque in blood vessels—which reduces blood flow to the brain. Over time, reduced cerebral blood flow contributes to cognitive decline and increases amyloid accumulation in the Alzheimer’s brain.
A lipid panel measures total cholesterol, LDL, HDL, and triglycerides, providing clinicians with information about stroke risk and vascular contributions to cognitive decline. A 70-year-old man with total cholesterol above 240 mg/dL and elevated triglycerides is at much higher risk of vascular dementia than someone with well-controlled lipids. Blood pressure measurements often accompany lipid testing because hypertension directly damages small blood vessels in the brain through a process called cerebral amyloid angiopathy. Managing cholesterol and blood pressure before cognitive decline is advanced offers the best chance of slowing or preventing progression.
